Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease

被引:0
|
作者
Zhang, Yizhi [1 ,2 ]
Chen, Yu [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Dept Liver Dis 4, Difficult & Complicated Liver Dis & Artificial Li, 8 Xi Tou Tiao,Youanmenwai St, Beijing 100069, Peoples R China
[2] Beijing Municipal Key Lab Liver Failure & Artific, Beijing 100069, Peoples R China
关键词
Autophagy; Lipophagy; Mitophagy; Reticulophagy; Non-alcoholic fatty liver disease; ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL PERMEABILITY TRANSITION; LIPID DROPLETS; INSULIN-RESISTANCE; QUALITY-CONTROL; SELECTIVE AUTOPHAGY; HEPATIC STEATOSIS; OXIDATIVE STRESS; MECHANISMS; ASSOCIATION;
D O I
10.1097/CM9.0000000000002263
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a disorder of lipid metabolism. The lipotoxic intermediates of lipid metabolism cause mitochondrial dysfunction and endoplasmic reticulum stress. Organelle-specific autophagy is responsible for the removal of dysfunctional organelles to maintain intracellular homeostasis. Lipophagy contributes to lipid turnover by degrading lipid droplets. The level of autophagy changes during the course of NAFLD, and the activation of hepatocyte autophagy might represent a method of treating NAFLD.
引用
收藏
页码:1673 / 1681
页数:9
相关论文
共 50 条
  • [21] Preclinical models of non-alcoholic fatty liver disease
    Santhekadur, Prasanna K.
    Kumar, Divya P.
    Sanyal, Arun J.
    JOURNAL OF HEPATOLOGY, 2018, 68 (02) : 230 - 237
  • [22] Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives
    Flessa, Christina-Maria
    Kyrou, Ioannis
    Nasiri-Ansari, Narjes
    Kaltsas, Gregory
    Papavassiliou, Athanasios G.
    Kassi, Eva
    Randeva, Harpal S.
    CURRENT OBESITY REPORTS, 2021, 10 (02) : 134 - 161
  • [23] The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
    Xu, Hao
    Wang, Lin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [24] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538
  • [25] Liver transplantation and non-alcoholic fatty liver disease
    Petros Zezos
    Eberhard L Renner
    World Journal of Gastroenterology, 2014, (42) : 15532 - 15538
  • [26] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245
  • [27] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [28] Non-alcoholic Fatty Liver Disease in Children
    Muzurovic, Emir
    Polyzos, Stergios A.
    Mikhailidis, Dimitri P.
    Borozan, Sanja
    Novosel, Dusanka
    Cmiljanic, Oleg
    Kadic, Natasa
    Mantzoros, Christos S.
    CURRENT VASCULAR PHARMACOLOGY, 2023, 21 (01) : 4 - 25
  • [29] Epidemiology of Non-Alcoholic Fatty Liver Disease
    Bellentani, Stefano
    Scaglioni, Federica
    Marino, Mariano
    Bedogni, Giorgio
    DIGESTIVE DISEASES, 2010, 28 (01) : 155 - 161
  • [30] Lipidomics in non-alcoholic fatty liver disease
    Kartsoli, Sofia
    Kostara, Christina E.
    Tsimihodimos, Vasilis
    Bairaktari, Eleni T.
    Christodoulou, Dimitrios K.
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (08) : 436 - 450